Results 251 to 260 of about 24,770 (274)

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial

European Journal of Heart Failure, 2011
Felix Mehrhof, Frank Edelmann, Rolf Wachter   +2 more
exaly  

Molecular mechanism of ion-pair releasing from acrylic pressure sensitive adhesive containing carboxyl group: Roles of doubly ionic hydrogen bond in the controlled release process of bisoprolol ion-pair

Journal of Controlled Release, 2018
Chao Liu, Liang Fang
exaly  

Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS‐II) trial

European Journal of Heart Failure, 2010
Davide Castagno, Pardeep S Jhund, John J V Mcmurray   +2 more
exaly  

Meta-Analysis of Carvedilol Versus Beta 1 Selective Beta-Blockers (Atenolol, Bisoprolol, Metoprolol, and Nebivolol)

American Journal of Cardiology, 2013
James J Dinicolantonio
exaly  

Mechanism study on ion-pair complexes controlling skin permeability: Effect of ion-pair dissociation in the viable epidermis on transdermal permeation of bisoprolol

International Journal of Pharmaceutics, 2017
Chao Liu
exaly  

Bisoprolol in experimental cancer cachexia

European Journal of Heart Failure Supplements, 2008
K. Schmidt, Stefan D. Anker, Sandra Palus, K. Hartmann, V.C. Flach, T. Braun, Jochen Springer   +6 more
openaire   +2 more sources

The Cardiac Insufficiency Bisoprolol Study II

The Lancet, 1999
Yoseph A. Mekori, Amit Segev
openaire   +4 more sources

Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial

European Journal of Heart Failure, 2009
Nathaniel M Hawkins, John J V Mcmurray
exaly  

Simulation of the pharmacokinetics of bisoprolol in healthy adults and patients with impaired renal function using whole-body physiologically based pharmacokinetic modeling

Acta Pharmacologica Sinica, 2012
Guo-Fu Li
exaly  

Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease

Cardiovascular Drugs and Therapy, 2021
exaly